Israel | Imports and Exports | World | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Israel totalled $ 220 million in 2023. Sales of commodity group 3002 from Israel went up by 28% compared to 2022: exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" went up by $ 48 million (cumulative exports of commodity group 3002 from Israel amounted $171 million in 2022)
Exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" amounted to 0.367% of total exports from Israel (cumulative merchandise exports from Israel totalled $ 59 billion in 2023). The share of commodity group 3002 in total exports from Israel increased by 0.131 p.p. compared to 2022 (it was 0.236% in 2022 and cumulative exports from Israel were equal to $ 72 billion).
Exports of commodity group 3002 amounted to 12.2% of total sales of group "" from Israel in 2023 (the value of exports of commodity group from Israel amounted to $1.8 billion in 2023). The share of exports of commodity group 3002 in sales of commodity group from Israel increased by 6.81 p.p. compared to 2022 (it was 5.4% in 2022, and exports of commodity group from Israel were $3.17 billion).
Where does Israel export Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc?
Top export destinations of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Israel in 2023:
- USA with a share of 43% (95 million US$)
- Brazil with a share of 9.98% (21 million US$)
- Russia with a share of 6.1% (13.4 million US$)
- Italy with a share of 6.08% (13.4 million US$)
- India with a share of 4.95% (10.9 million US$)
- Indonesia with a share of 4.07% (8.98 million US$)
- Canada with a share of 2.47% (5.45 million US$)
- Austria with a share of 2.43% (5.36 million US$)
- Belgium with a share of 2.38% (5.26 million US$)
- Turkey with a share of 2.31% (5.1 million US$)
Exports structure of 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc - from Israel in 2023 represented by the following main commodity groups:
- 1.02% (2.24 million US$): 300290 - Human blood; animal blood prepared for therapeutic/prophylactic/diagnostic uses; toxins, cultures of micro-organisms (excl. yeasts) & sim. products
The value of imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to Israel totalled $ 1.23 billion in 2023. Sales of commodity group 3002 to Israel decreased by 10.4% in value terms compared to 2022. imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" decreased by $ 143 million (the value of imports of commodity group 3002 to Israel was equal to $1.37 billion in 2022)
Imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" accounted for 1.48% of total import flow to Israel (in 2023, total imports to Israel amounted to $ 83 billion). The share of commodity group 3002 in total imports to Israel increased by 0.205 p.p. compared to 2022 (it was 1.27% in 2022 and cumulative imports to Israel were equal to $ 107 billion).
Imports of commodity group 3002 reached 37% of total imports of group "" to Israel in 2023 (imports of commodity group to Israel totalled $3.3 billion in 2023). The share of purchases of commodity group 3002 in imports of commodity group to Israel went down by 0.778 p.p. compared to 2022 (it was 38% in 2022, and imports of commodity group to Israel accounted for $3.61 billion).
Where does Israel import Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc from?
Top trading partners (import of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc") of Israel in 2023:
- USA with a share of 18.7% (231 million US$)
- Switzerland with a share of 16.8% (207 million US$)
- Germany with a share of 14% (172 million US$)
- Ireland with a share of 12.7% (157 million US$)
- Spain with a share of 9.82% (121 million US$)
- France with a share of 4.75% (58 million US$)
- Netherlands with a share of 4.6% (56 million US$)
- Italy with a share of 3.72% (45 million US$)
- Belgium with a share of 3.66% (45 million US$)
- United Kingdom with a share of 3.34% (41 million US$)
Imports structure of 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc - to Israel in 2023 represented by the following main commodity groups:
- 1.1% (13.6 million US$): 300290 - Human blood; animal blood prepared for therapeutic/prophylactic/diagnostic uses; toxins, cultures of micro-organisms (excl. yeasts) & sim. products
